Skip to content

Clinical Efficacy Evaluation and Microbiomics Study of Yin-Yang Conditioning Moxibustion Intervention in Obese Patients with Spleen Deficiency and Dampness Retention Syndrome

Clinical Efficacy Evaluation and Microbiomics Study of Yin-Yang Conditioning Moxibustion Intervention in Obese Patients with Spleen Deficiency and Dampness Retention Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001191
Enrollment
Unknown
Registered
2025-06-16
Start date
2025-07-10
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obese Patients with Spleen Deficiency and Dampness Retention Syndrome

Interventions

Sponsors

Hubei Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: (1) Individuals who meet the diagnostic criteria for abdominal obesity with spleen deficiency and dampness retention syndrome and are confirmed to have abdominal obesity of the spleen deficiency and dampness retention type; (2) Age: 18–55 years old; (3) Those who sign the informed consent form and voluntarily accept the intervention methods of this project. Note: Patients must meet all three of the above criteria to be included in this study.

Exclusion criteria

Exclusion criteria: (1) With endocrine diseases (such as polycystic ovary syndrome Cushing's syndrome hypothyroidism etc.); (2) Complicated with uncontrolled diabetes or hypertension (systolic blood pressure =160 mmHg diastolic blood pressure =100 mmHg) or severe diseases of the heart liver kidney hematopoietic system or psychiatric disorders; (3) Pregnant lactating or menopausal women; women planning to become pregnant within 12 weeks; (4) History of clinically diagnosed eating disorders (such as bulimia hyperphagia anorexia etc.) and weight fluctuation >5 kg in the past three months; (5) Taking medications known to affect body weight or appetite (such as weight-loss drugs corticosteroids antidepressants tranquilizers non-selective systemic antihistamines nicotine substitutes hypoglycemic drugs etc.) in the past three months; or those with plans to quit smoking or drinking; (6) History of surgical weight loss or postoperative adhesions; (7) Participated in weight-loss clinical studies or currently using dietary/exercise therapy for weight loss in the past three months; (8) Inability to cooperate with or adhere to the treatment during the study period. Note: Any patient meeting any one of the above criteria will be excluded.

Design outcomes

Primary

MeasureTime frame
Waist circumference;

Secondary

MeasureTime frame
Inbody body composition analysis includes: body water body fat percentage protein inorganic salts visceral fat area and basal metabolic rate.;Four blood lipid indicators;Body Weight BMI Hip Circumference Waist-Hip Ratio;Assessment of Quality of Life and Psychological State;Tongue image acquisition oral and intestinal microbiota detection;

Countries

China

Contacts

Public ContactWei Huang

Hubei Provincial Hospital of Traditional Chinese Medicine

24231637@qq.com13986083982

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026